Medical device company Aethlon Medical Inc (Nasdaq:AEMD) revealed on Thursday the appointment of Lisa M. Boswell as director of its Quality Systems and Regulatory Affairs.
Boswell's leadership will be critical as the company move the Hemopurifier through the next stages of development. Given the recent designation of the Hemopurifier as a Breakthrough Device by the US FDA, it is extremely important that robust Quality Systems and Manufacturing processes are in place to support ongoing development and planned clinical trials, added its interim CEO, Timothy C. Rodell, M.D.
Most recently, Boswell has served as director, Quality Assurance and Regulatory Affairs at ZOLL Data Systems Inc.
Previously, Boswell has worked for ten years in positions of increasing responsibility in Quality Control at GlobeImmune Inc.
TELA Bio launches LIQUIFIX for US hernia surgery
Cognizant and NVIDIA partner to revolutionize drug discovery with generative AI
Neupulse raises funds for Tourettes Syndrome wearable tech
Bonesupport gains FDA clearance for CERAMENT G in open fractures
Epitomee submits Weight Loss Capsule for FDA approval in US
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon